Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022

EX-10.16 5 ex1016-calsadasalaryupdate.htm EX-10.16 Document

Exhibit 10.16

Cris Calsada Yearly Discretionary Base Salary Increase

The Board of Directors (the “Board”) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Ms. Calsada’s annual base salary to $340,725, effective January 1, 2022.